Search results
Moderna’s New Flu-COVID Combi mRNA Vaccine Outperforms Separate Shots In Trials
IFLScience· 5 days agoPharmaceutical company Moderna has announced that a combination vaccine it has been developing...
Moderna's COVID-Flu Vaccine Shows Stronger Immune Response Than Individual Shots, Late-Stage Trial...
Forbes· 6 days agoModerna on Monday said its combination COVID-19 and flu shot elicits a stronger immune response...
COVID-flu combo vaccine shows ‘positive’ results in phase 3 trials, Moderna says: A 'two-for' option
Fox News via Yahoo News· 5 days agoModerna, which is developing a combination COVID-flu vaccine, announced on Monday that in phase 3...
Moderna’s Covid-19 vaccine meets primary efficacy endpoint in Phase III trial
Clinical Trials Arena via Yahoo Finance· 2 days agoModerna has announced that its Phase III clinical trial of the investigational next-generation Covid...
Moderna's COVID-flu combo shot outperformed existing vaccines in a late-stage trial
Quartz· 6 days agoS. Food and Drug Administration (FDA) in May approved Moderna’s mRNA-based respiratory syncytial...
Moderna COVID/flu combo vaccine superior to separate shots in trial
Reuters via AOL· 6 days agoModerna said on Monday its combination vaccine to protect against both COVID-19 and influenza...
Moderna Combination Shot Outperforms Standalone Flu, Covid-19 Jabs
Barrons.com· 6 days agoThe results could to upend the flu market if they withstand scrutiny from regulators. More than half...
Moderna’s COVID, flu combination vaccine shows stronger immune response, company announces
WHIO-TV 7 Dayton· 5 days agoModerna is working on a single vaccine that it says will protect people against both COVID-19 and...
A new Alzheimer's drug, combined COVID and flu vaccine update, and salmonella concerns. 3 health...
Yahoo Life Style via AOL· 14 hours agoThe company aims to launch this combo vaccine by the 2025 respiratory disease season, pending FDA...
Moderna Announces Positive Phase 3 Efficacy Data for mRNA-1283, the Company’s Next Generation COVID-...
Digital Journal· 3 days agomRNA-1283 met its primary vaccine efficacy endpoint in a Phase 3 trial, demonstrating non-inferior vaccine efficacy against COVID-< ...